Superworth

Whitehawk Therapeutics EPS WHWK

Diluted earnings per share by quarter and over the last twelve months, from 2010.

Last 12 months, to Jun 30, 2026
−$1.12
Latest quarter, Q2 FY26
−$0.20
Fiscal year 2025
$0.47

Whitehawk Therapeutics' earnings per share was −$1.12 over the twelve months to Jun 30, 2026.

In its latest quarter, Q2 FY26, it was −$0.20.

Earnings per share over time

Open the interactive chart, with overlays and comparisons

Fiscal year by fiscal year

Fiscal yearEPSChange
FY2025$0.47n/a
FY2024−$2.35n/a
FY2023−$2.44n/a
FY2022−$2.73n/a
FY2021−$12.69n/a
FY2020−$1.23n/a
FY2019−$0.02n/a
FY2018−$0.01n/a
FY2017−$0.06n/a
FY2016−$0.83n/a
FY2015$0.00n/a
FY2014$0.00n/a
FY2013$0.00n/a
FY2012$0.00n/a
FY2011$0.00n/a

Each fiscal year is the twelve months to its fourth quarter.

Quarter by quarter

QuarterEndedEPSOn a year earlierLast 12 months
Q2 FY26−$0.20n/a−$1.12
Q1 FY26−$0.32−117%−$1.68
Q4 FY25−$0.34n/a$0.47
Q3 FY25−$0.26n/a$0.14
Q2 FY25−$0.76n/a−$0.06
Q1 FY25$1.83n/a$0.16
Q4 FY24−$0.67n/a−$2.35
Q3 FY24−$0.46n/a−$2.28
Q2 FY24−$0.54n/a−$2.42
Q1 FY24−$0.68n/a−$2.55
Q4 FY23−$0.60n/a−$2.44
Q3 FY23−$0.60n/a−$2.36

Against its peers

Companies in Drug Manufacturers - General nearest Whitehawk Therapeutics' size, closest first, today.

CompanyEPS, 12 monthsGrowth
WHWKWhitehawk Therapeutics−$1.12
NATRNatures Sunshine Products$1.01+36% a year
LFVNLifevantage$0.40−46% a year
ARVNArvinas$0.16
SPROSpero Therapeutics$0.11
PBYIPuma Biotechnology$0.52−47% a year
IRWDIronwood Pharmaceuticals$0.77
ZVRAZevra Therapeutics$0.93
CRMDCorMedix$2.13+184% a year
ATNMActinium Pharmaceuticals$0.36
COLLCollegium Pharmaceutical$1.24+19% a year
Peer median$0.65

What the EPS figure tells you

Net income divided by diluted shares. The denominator of PE.

One-off charges and gains swing it. The TTM view smooths a single odd quarter.

More on Whitehawk Therapeutics

Valuation data, not investment advice. Prices as of . Reported figures come from the company's filings with the SEC.